Hear about the Risk Evaluation On Generic Approvals Of US Pharmaceuticals

LinkedIn ([link removed] )

YouTube ([link removed] )

Facebook ([link removed] )

X ([link removed] )

Instagram ([link removed] )

Website ([link removed] )

John,

A Health Podyssey's Rob Lott will interview Jennifer Kao about her upcoming paper from the October 2025 issue of Health Affairs and take questions from a live audience.

Kao's paper explores the impact of risk evaluation and mitigation strategies on generic approvals of US pharmaceutical products.

Join us for a live taping ([link removed] ) of A Health Podyssey on October 22 at 11am ET.

This event is free for all.

Join Us
([link removed] )

Sign up for our free daily and weekly newsletters ([link removed] ) to never miss an event, an article, podcast, or health policy brief.

health-affairs-opioid-crisis-44-09_eNewsletter-banner ([link removed] )

LinkedIn ([link removed] )

YouTube ([link removed] )

Facebook ([link removed] )

X ([link removed] )

Instagram ([link removed] )

Website ([link removed] )

About Health Affairs

Health Affairs is the leading peer-reviewed journal ([link removed] ) at the intersection of health, health care, and policy. Published monthly by Project HOPE, the journal is available in print and online.

Sign up for all of our newsletters ([link removed] ) , including Health Affairs Today and Health Affairs Sunday Update.

Project HOPE ([link removed] ) is a global health and humanitarian organization that places power in the hands of local health care workers to save lives across the globe. Project HOPE has published Health Affairs since 1981.

Copyright © Project HOPE: The People-to-People Health Foundation, Inc.

Privacy Policy ([link removed] )

Health Affairs, 1220 19th St. NW, Suite 800, Washington, DC 20036, United States, 202-408-6801

Manage preferences ([link removed] )